TickerFacts.

Company research / CXXIF

C21 Investments Inc. (CXXIF)

Build a valuation ↗↓ Download CSV

CIK 0000831609 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, C21 Investments Inc. reported revenue of $32.61M. Revenue grew 8.3% from the prior annual period.

Key ratios (year ended 2026-03-31)

41.7%
Gross margin
7.0%
Operating margin
-9.9%
Net margin
-12.8%
Return on year-end equity
8.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 6-K · 2026-08-21

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2026-03-312025-03-312024-03-312024-01-312023-01-312022-01-312021-01-312020-01-31
Revenue$32.61M$30.12M—$28.29M$28.89M$32.98M$33.47M—
Cost of Revenue$19.01M$17.56M—$17.14M$15.49M$14.17M$15.42M—
Gross Profit$13.61M$12.56M—$11.15M$13.40M$18.81M$18.05M—
Operating Income$2.28M$1.28M—$1.47M$3.96M$9.75M$9.24M—
Net Income-$3.24M-$3.97M—-$3.31M$293.2K$9.95M-$7.83M—
EPS (Diluted)$-0.03$-0.03—$-0.03$0.00$0.08$-0.07—
Total Assets$54.42M$57.00M$55.23M$54.53M$58.31M$61.84M$66.82M—
Total Liabilities$28.99M$28.32M$24.25M$23.48M$24.00M$28.12M$43.56M—
Shareholders' Equity$25.43M$28.68M$30.97M$31.05M$34.32M$33.73M$23.26M$13.61M
Operating Cash Flow$1.36M$1.37M—$3.26M$5.97M$8.44M$8.48M—
Capital Expenditures$244.8K$406.7K—$521.6K$442.3K$2.56M$227.8K—
Shares Outstanding117.84M118.00M120.05M120.05M120.05M120.05M117.06M—
Weighted Average Diluted Shares118.47M120.59M—122.88M122.88M121.14M104.84M—
EPS (Basic)$-0.03$-0.03—$-0.03$0.00$0.08$-0.07—